Skip to content

Effect of Antibiotic Treatment Course on Clinical Outcome after Two-stage Revision of Prosthetic Joint Infection

Effect of Antibiotic Treatment Course on Clinical Outcome after Two-stage Revision of Prosthetic Joint Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031697
Enrollment
Unknown
Registered
2020-04-07
Start date
2020-04-07
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prosthetic joint infection

Interventions

Case series:After receiving intravenous antibiotics treatment for 2 weeks, and clinician determines whether to continue with any antibiotics.

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as PJI according to MSIS standard; 2. The result of positive microbial culture or second-generation sequencing is confirmed as pathogenic bacteria by experts; 3. The patients with chronic infection develope after the first replacement for 4 weeks and were not infected by acute blood source; 4. Patients with infection control and two-stage joint revision who were treated with antibiotics (at least 6 weeks) in the first stage after septal implantation; 5. Patients aged >=18 years; 6. Patients who voluntarily participate in the study and are physically and mentally resistant to the treatment process and tests of the study, have signed the informed consent, and have passed the review of all hospital ethics committees participating in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with fungal or mycobacterial infection; 2. Patients with multi drug resistant bacteria infection; 3. Patients whose operation plans are changed due to various reasons, such as one-stage joint revision or joint fusion; 4. The patients who are cultured the pathogenic bacteria again during the second operation; 5. Patients with other diseases that may affect the results, such as immune deficiency, liver and kidney dysfunction; 6. Patients whose life expectancy is less than half a year; 7. The investigator judges patients who no longer meet the criteria of the study due to compliance issues.

Design outcomes

Primary

MeasureTime frame
Clearance rate of infection;Adverse events related to PJI;

Secondary

MeasureTime frame
Functional score after replantation;The rate of prosthesis loosening after replantation, the rate of revision, and the rate of prosthesis removal required;Incidence of antibiotic-related complications;

Countries

China

Contacts

Public ContactZhang Wenming

The First Affiliated Hospital of Fujian Medical University

zhangwm0591@163.com+86 13950391800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026